BVES通过PP2A调控c-Myc稳定性并抑制结肠炎诱导的肿瘤发生
本研究探讨血管心外膜物质(BVES)在结肠炎相关癌症(CAC)中的作用。在溃疡性结肠炎(UC)伴或不伴CAC患者中,BVES启动子高甲基化导致其mRNA在肿瘤中降低,且远隔非恶性黏膜也出现高甲基化。Bves-/-小鼠经AOM/DSS处理后肿瘤多发性和异型增生程度增加,其肿瘤显示Wnt激活和c-Myc水平升高。机制上,BVES与PP2A调节亚基PR61α相互作用介导c-Myc降解。结论认为BVES缺失通过Wnt信号失调和c-Myc促进炎症性肿瘤发生,BVES启动子甲基化状态可能作为CAC生物标志物。
要点
- CAC患者肿瘤中BVES mRNA因启动子高甲基化而降低,远隔非恶性黏膜也出现高甲基化。
- Bves-/-小鼠经AOM/DSS诱导后肿瘤多发性和异型增生程度增加,肿瘤显示Wnt激活和c-Myc升高。
- BVES与PP2A调节亚基PR61α相互作用介导c-Myc降解,BVES启动子甲基化可能作为CAC生物标志物。
核心结论
- BVES缺失通过Wnt信号失调和癌基因c-Myc促进炎症性肿瘤发生。
- BVES启动子甲基化状态可能作为CAC的生物标志物。
研究设计与样本
- 使用Infinitum HumanMethylation450芯片检测UC伴或不伴CAC患者的BVES启动子甲基化状态。
- 在包含正常结肠和CAC样本的组织微阵列中测量BVES mRNA水平。
- 对Bves-/-和野生型对照小鼠给予氧化偶氮甲烷(AOM)和葡聚糖硫酸钠(DSS)诱导肿瘤形成。
- 利用酵母双杂交筛选鉴定BVES相互作用蛋白,并在多种细胞系中进行机制研究。
主要发现
- CAC患者肿瘤中BVES mRNA因启动子高甲基化而降低,且远隔非恶性外观黏膜同时存在BVES启动子高甲基化。
- 实验性炎症致癌过程中Bves表达降低,Bves-/-小鼠经AOM/DSS处理后肿瘤多发性和异型增生程度增加。
- Bves-/-肿瘤的分子分析显示Wnt激活和c-Myc水平升高。
- BVES与PR61α(蛋白磷酸酶2A调节亚基)相互作用以介导c-Myc破坏。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Blood vessel epicardial substance (BVES) is a tight junction-associated protein that regulates epithelial-mesenchymal states and is underexpressed in epithelial malignancy. However, the functional impact of BVES loss on tumourigenesis is unknown. Here we define the in vivo role of BVES in colitis-associated cancer (CAC), its cellular function and its relevance to patients with IBD. DESIGN: We determined BVES promoter methylation status using an Infinium HumanMethylation450 array screen of patients with UC with and without CAC. We also measured BVES mRNA levels in a tissue microarray consisting of normal colons and CAC samples. Bves-/- and wild-type mice (controls) were administered azoxymethane (AOM) and dextran sodium sulfate (DSS) to induce tumour formation. Last, we used a yeast two-hybrid screen to identify BVES interactors and performed mechanistic studies in multiple cell lines to define how BVES reduces c-Myc levels. RESULTS: BVES mRNA was reduced in tumours from patients with CAC via promoter hypermethylation. Importantly, BVES promoter hypermethylation was concurrently present in distant non-malignant-appearing mucosa. As seen in human patients, Bves was underexpressed in experimental inflammatory carcinogenesis, and Bves-/- mice had increased tumour multiplicity and degree of dysplasia after AOM/DSS administration. Molecular analysis of Bves-/- tumours revealed Wnt activation and increased c-Myc levels. Mechanistically, we identified a new signalling pathway whereby BVES interacts with PR61α, a protein phosphatase 2A regulatory subunit, to mediate c-Myc destruction. CONCLUSION: Loss of BVES promotes inflammatory tumourigenesis through dysregulation of Wnt signalling and the oncogene c-Myc. BVES promoter methylation status may serve as a CAC biomarker.
引用
- Parang B, Kaz AM, Barrett CW, et al. BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Gut. 2016. PMID: 28389570. doi:10.1136/gutjnl-2015-310255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。